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Abstract 
Intestinal health problems are a major issue in the poultry industry. Quantifiable easy-to-measure biomarkers for 
intestinal health would be of great value to monitor subclinical intestinal entities that cause performance problems 
and to evaluate control methods for intestinal health. The aim of the study was to identify host protein biomarkers 
for intestinal inflammation and intestinal barrier damage. Proteomic analysis was conducted on ileal and colonic 
content samples of broilers under an experimental gut damage and inflammation model. Effects of the challenge 
treatment resulted in a worse gut condition based on macroscopic gut appearance (p < 0.0001). Also microscopic 
changes such as shortening of the villi and increased crypt depth (p < 0.0001) as well as higher infiltration of T-lym-
phocytes (p < 0.0001) were seen in the duodenal tissue of challenged animals. Several candidate proteins associated 
with inflammation, serum leakage and/or tissue damage were identified with an increased abundance in intestinal 
content of challenged animals (p < 0.05). Conversely, brush border enzymes were less abundant in intestinal content 
of challenged animals (p < 0.05). These candidate biomarkers have potential to be used in the field for detection of gut 
barrier failure in broilers.
© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/
publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
The production and consumption of broiler meat is rising 
rapidly worldwide [1, 2]. Of all terrestrial meat-producing 
animals, broilers probably have the highest relative daily 
weight gain and the lowest feed conversion. Therefore, 
broiler meat is considered to be a relatively sustainable 
source of animal protein [3]. Unfortunately, disturbances 
of intestinal tract function are common in broilers, which 
can hamper their feed conversion due to inefficient 
digestion and absorption of nutrients [4]. These distur-
bances are associated with necrotic enteritis, coccidiosis 
[5, 6] and a range of ill-defined enteric syndromes of 
unclear etiology, sometimes classified under the common 
denominator of “dysbiosis”. They constitute the major 
challenge to the broiler production today.
The intestinal mucosa is responsible for absorption of 
nutrients. To maintain a good intestinal barrier function, 
an optimal balance between the mucus layer, the intes-
tinal epithelium and the microbiota is crucial [7]. A sin-
gle layer of columnar epithelial cells which are connected 
by tight junctions is a crucial component of the intesti-
nal barrier. It acts as a first protection against invasion of 
potentially harmful microorganisms, antigens and tox-
ins from the intestinal lumen [8, 9]. Reduced tight junc-
tion integrity and epithelial damage can thus result in 
a ‘leaky gut’ and are likely the main drivers for gut wall 
morphology changes, inflammation, systemic infection 
and malabsorption [10, 11]. Poor gut health in broilers 
has indeed been associated with intestinal villus short-
ening [12], immune cell infiltration in the mucosal wall 
[13], and systemic spread of bacteria to organs, as is the 
case in bacterial chondronecrosis with osteomyelitis in 
broilers [14]. The importance of intestinal health in broil-
ers is illustrated by the observation that more than 50% 
of the therapeutic use of antibiotics in broilers in the 
European Union, is to control intestinal pathologies [15]. 
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Therapeutic usage of antibiotics may be the sole viable 
solution in flocks with severe advanced intestinal health 
problems.
Alternative, non-antibiotic, solutions for maintain-
ing intestinal health include diet optimization and the 
use of feed additives, such as probiotics, acidifiers and 
essential oils [16]. The use of these products as preven-
tive or curative tool requires early detection of intestinal 
health problems in broilers. Unfortunately, for the early 
stages of intestinal health defects, clinical indications 
are lacking. For measurement of the subclinical level of 
dysbiosis, field veterinarians and researchers use a mac-
roscopic scoring system [17] but this is labor-intensive 
and requires necropsy of the animals. These observa-
tions have fueled intensive research hunting for specific 
biomarkers of intestinal health, or deficiency thereof 
[18]. In humans, fecal markers such as calprotectin, a 
stable protein that is contained in secretory granules of 
neutrophils, are used to evaluate inflammation in case of 
severe gut disease [19, 20]. In poultry, several attempts 
have been reported to identify suitable biomarkers for 
gut barrier failure, mostly in serum samples, either with 
or without an experimental intervention [10, 21]. Most of 
these studies have analyzed specific candidate biomark-
ers, often homologues of molecules considered to be of 
value in detection of gut health problems in mammals. 
Until now, few seem to be ready for practical use in the 
field. Recently, ovotransferrin has been proposed as fecal 
biomarker for intestinal leakage caused by coccidiosis 
and necrotic enteritis in broilers [22].
A first step in the development of a reliable, rapid and 
non-invasive diagnostic assay to monitor gut health is 
the identification of suitable biomarkers. Biomarkers for 
intestinal health defects, that can be used on fresh fecal 
droppings or litter, would be a huge asset. The aim of this 
study, therefore, was to identify intestinal biomarkers for 
evaluation of intestinal health using a gut damage model 
in broilers. Preferably the biomarkers should be of pep-
tide or protein nature, as this may ultimately allow detec-
tion by a simple immunoassay. Therefore, an unbiased 
proteomic approach was used.
Materials and methods
Animal trials and sample collection
The experiment was approved by the Ethical Committee 
of Poulpharm BVBA, Izegem, Belgium (bacterial enteritis 
trial; P1606-FP) with approval number LA1400564. The 
animal experiment was carried out in accordance with 
approved guidelines.
Bacterial inoculum
A bacterial inoculum consisting of a mixture of Escheri-
chia coli (G.78.71), Enterococcus faecalis (G.78.62), 
Lactobacillus salivarius (LMG22873), Lactobacillus 
crispatus (LMG49479), Clostridium perfringens (netB-) 
(D.39.61) and Ruminococcus gnavus (LMG27713) was 
prepared. Luria–Bertani broth (LB, Oxoid) was used for 
growing E. coli. E. faecalis and C. perfringens were grown 
in Brain Heart Infusion (BHI, Sigma, Belgium) broth. 
Man–Rogosa–Sharpe (MRS, Oxoid) medium was used 
for the growth of L. crispatus and L. salivarius. For the 
growth of R. gnavus, anaerobic M2GSC medium (pH 6) 
as described by Miyazaki et  al. [23] was used but with 
15% clarified rumen fluid instead of 30% and addition of 
1 mg/mL cysteine HCl and 4 mg/mL  NaHCO3 after auto-
claving. E. coli and E. faecalis were cultured in aerobic 
conditions at 37  °C. Lactobacillus spp. were cultured in 
an micro aerobic (5%  O2) incubator, C. perfringens and 
R. gnavus were cultured in an anaerobic chamber (gas 
mixture 80%  N2, 10%  CO2 and 10%  H2, GP[concept], 
Jacomex, France) at 37  °C. The bacterial cells were col-
lected by centrifugation (10  000  rpm, 10  min, 20  °C) 
and each pellet was resuspended in anaerobic phos-
phate buffered saline (PBS, 1 mg/mL cysteine HCl, pH 6) 
whereby the number of colony-forming units (CFU)/mL 
was determined by counting the colonies on the plates 
of a tenfold serial dilution of the suspension before mix-
ing together. Table 1 is showing the final concentration of 
each strain after mixing the original cultures.
Study design
A total of 360  day-old broiler chicks (Ross 308) was 
obtained from a local hatchery and housed in floor pens 
on wood shavings. Throughout the study, feed and drink-
ing water were provided ad  libitum. The broilers were 
randomly assigned to two groups, a control and chal-
lenge group (9 pens per treatment and 20 birds per pen). 
All animals were fed a commercial feed till day 12 when 
the feed was switched to a wheat (57.5%) based diet sup-
plemented with 5% rye (Table 2). From day 12 to 18, all 
animals from the challenge group received 10  mg flo-
rfenicol and 10 mg enrofloxacin per kg body weight via 
the drinking water daily. After the antibiotic treatment, 
1  mL of the bacterial cocktail consisting of Escherichia 
coli (G.78.71), Enterococcus faecalis (G.78.62), Lactoba-
cillus salivarius (LMG22873), Lactobacillus crispatus 
(LMG49479), Clostridium perfringens (netB-) (D.39.61) 
and Ruminococcus gnavus (LMG27713) was given daily 
by oral gavage from day 19 till 21. On day 20, the ani-
mals were administered 1  mL of a coccidial suspension 
consisting of 60  000 oocysts of Eimeria acervulina and 
30  000 oocysts of Eimeria maxima via oral gavage. At 
day 26, 3 birds per pen were euthanized. The duodenal 
loop was sampled for histological examination and ileal 
and colonic content was collected and stored at − 20 °C 
until required for protein extraction. At day 12 and day 
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26, birds and feed were weighed in order to determine 
daily weight gain (DWG), daily feed intake (DFI) and feed 
conversion ratio (FCR) (Table 3). A schematic presenta-
tion of the protocol is shown in Figure 1.
Macroscopic gut wall appearance scoring system
The macroscopic appearance of the gut was evalu-
ated using a previously described scoring system [17], 
in which 10 parameters were evaluated and assigned 
0 (absent) or 1 (present), resulting in a total score 
between 0 and 10. A total score of 0 to 2 represents a 
normal appearance of the intestinal tract while score 
10 points to severe deviations from the normal appear-
ance. The parameters are (1) “ballooning” of the gut; 
(2) inflammation, cranial to Meckel’s diverticulum; 
(3) macroscopically visible and tangible fragile small 
intestine cranial to Meckel’s diverticulum; (4) loss of 
tonus at longitudinal cutting of the intestine cranial to 
the Meckel’s diverticulum within 3  s after incision; (5) 
abnormal appearance of the intestinal content (excess 
mucus, orange content, gas) cranial to Meckel’s diver-
ticulum; (6, 7, 8, 9) are identical to (2, 3, 4, 5) but caudal 
to Meckel’s diverticulum and (10) presence of undi-
gested particles in the colon.
Table 1 Composition of the bacterial cocktail for oral inoculation 
Broilers in the challenge group were orally inoculated with 1 mL of a bacterial cocktail consisting of Escherichia coli, Enterococcus faecalis, Lactobacillus salivarius, 
Lactobacillus crispatus, Clostridium perfringens (netB-) and Ruminococcus gnavus on day 19, 20 and 21, with number of colony-forming units (CFU) per strain as 
indicated in the table.
Bacterial strain Day 19 (CFU/mL) Day 20 (CFU/mL) Day 21 (CFU/mL)
E. coli 2.11 × 109 1.22 × 109 2.28 × 109
Enterococcus faecalis 3.44 × 109 2.28 × 1010 3.56 × 109
Lactobacillus salivarius 4.78 × 107 1.16 × 107 2.39 × 107
Lactobacillus crispatus 1.89 × 109 7.78 × 107 7.22 × 106
Clostridium perfringens 1 × 107 1.06 × 107 2.78 × 108
Ruminococcus gnavus 2.89 × 108 2.78 × 108 3.17 × 108
Table 2 Composition and nutrient content of the wheat/rye based broiler diet 
Starter diet, a commercial feed, administered to all broilers till day 11. From day 12 to 26, all animals received a grower diet, wheat (57.5%) supplemented with rye 
(5%).
Feedstuff Starter Grower Calculated nutrient 
composition
Starter Grower
% % % %
Wheat 55.13 57.87 Dry matter 88.45 88.38
Rye 0.00 5.00 Ash 5.11 4.79
Soy meal, crude fiber content < 50 22.86 22.86 Crude protein 20.85 18.98
Full fat soy beans 7.50 2.50 Crude fat 10.83 9.90
Rapeseed meal < 380 2.74 0.00 Crude fiber 2.93 2.49
Animal fat 7.20 7.20 Carbohydrates 48.46 51.95
Soybean oil 1.00 1.00 Starch 34.62 38.46
Premix (maize) 0.50 0.50 Sugars 4.77 4.53
Lime fine 1.11 1.11 NDF 10.52 9.93
Monocalcium phosphate 0.83 0.83 ADF 4.18 3.52
Salt 0.18 0.18 Calcium 0.69 0.66
NaHCO3 0.25 0.25 Phosphorus, total 0.57 0.54
l-Lysine HCl 0.30 0.30 Calcium/dP poultry 0.22 0.22
dl-Methionine 0.30 0.30 Magnesium 0.16 0.14
l-Threonine 0.10 0.10 Potassium 0.88 0.79
Sodium 0.15 0.15
Chloride 0.20 0.20
Base-excess (mEq/kg) 23.39 20.97
Linolic acid 2.38 1.92
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A coccidiosis scoring was performed as described by 
Johnson and Reid [24]. The animals were given a score 
for typical lesions associated with E. acervulina, E. max-
ima and E. tenella. For each species, a score was given 
between 0 (absent) and 4 (severe). A total coccidiosis 
score was calculated as the sum of the three individual 
Eimeria species scores.
Morphological parameters
The duodenal loops were fixated in 4% formaldehyde for 
24  h, dehydrated in xylene and embedded in paraffin. 
Sections of 4  µm were cut using a microtome (HM360, 
Thermo Scientific, Waltham, MA, USA) and processed 
as described by De Maesschalck et al. [25]. After staining 
with haematoxylin and eosin, morphological parameters 
were assessed using standard light microscopy. Villus 
length, measured from the crypt–villus junction to the 
villus tip, and crypt depth, measured from the junction to 
the base, in the duodenum were determined by random 
measurement of 12 villi per section using a Leica DM 
LB2 microscope equipped with a camera and a computer 
based image analysis program, LAS V4.1 (Leica Appli-
cation Suite V4, Wetzlar, Germany). The average villus 
length, crypt depth and villus-to-crypt ratio was deter-
mined for 3 animals per pen for 9 pens per treatment.
Immunohistochemical examination
Antigen retrieval was performed on 4 µm duodenal sec-
tions with a pressure cooker in citrate buffer (10  mM, 
pH 6). Slides were rinsed with washing buffer (Dako kit, 
K4011, Glostrup, Denmark) and blocked with peroxidase 
reagent (Dako, S2023) for 5 min. Slides were rinsed with 
distilled water and Dako washing buffer before incu-
bation with anti-CD3 primary antibodies (Dako  CD3, 
A0452) for 30  min at room temperature diluted 1:100 
in antibody diluent (Dako, S3022). After rinsing again 
with washing buffer, slides were incubated with labelled 
polymer-HRP anti-rabbit  (Envision+ System-HRP, 
K4011) for 30  min at room temperature. Before adding 
di-amino-benzidine  (DAB+) substrate and  DAB+ chro-
mogen (Dako kit, K4011) for 5  min, slides were rinsed 
2 times with washing buffer. To stop the staining, the 
slides were rinsed with distilled water, dehydrated using 
the Shandon Varistain-Gemini Automated Slide Stainer 
Table 3 Mean ± standard deviation of performance 
parameters 
Body weight (BW), daily weight gain (DWG), daily feed intake (DFI) and feed 
conversion ratio (FCR) was measured at day 12 and day 26 for the control and 
challenge group. Significant differences (p < 0.05) are shown in italic.
Time period Parameters Control Challenge p-value
Mean ± SD Mean ± SD
D1–D12 BW D12 (g) 290 ± 13 295 ± 11 0.485
DWG (g) 19.6 ± 1 20.2 ± 1 0.342
DFI (g) 24 ± 1 25 ± 1 0.614
FCR 1.25 ± 0.06 1.23 ± 0.05 0.321
D12–D26 BW D26 (g) 1375 ± 58 1187 ± 46 < 0.001
DWG (g) 78 ± 4 64 ± 4 < 0.001
DFI (g) 116 ± 6 108 ± 7 0.014
FCR 1.50 ± 0.07 1.69 ± 0.18 0.004
Figure 1 Schematic overview of the protocol of the in vivo challenge model. A total of 360 day-old broiler chicks (Ross 308) were randomly 
assigned to two groups, a control and a challenge group (9 pens per treatment and 20 broilers per pen). All animals were fed a commercial feed 
and switched to a wheat (57.5%) based diet supplemented with 5% rye on day 12. From day 12 to 18, all animals from the challenge group received 
daily 10 mg florfenicol and 10 mg enrofloxacin per kg body weight via the drinking water. After the antibiotic treatment, 1 mL of a bacterial cocktail 
consisting of E. coli, E. faecalis, L. salivarius and L. crispatus, C. perfringens (netB-) and R. gnavus was given daily by oral gavage from day 19 till 21. On 
day 20, the animals were administered a coccidial suspension consisting of 60 000 oocysts of E. acervulina and 30 000 oocysts of E. maxima. At day 
26, the birds were weighed and necropsy was performed on 3 birds per pen. The duodenal loop was sampled for histological examination and 
content from ileum and colon was collected for protein extraction.
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and counterstained with hematoxylin for 10 s. The slides 
were analyzed with a Leica DM LB2 microscope and a 
computer based image analysis program LAS V4.1 (Leica 
Application Suite V4, Germany) to measure  CD3 positive 
cells in a total area of 3.5 ± 0.5 mm2 which represents the 
area of approximately 10 to 12 villi.
Discovery proteomics
Sample preparation
Five hundred mg content of each colon and ileum sam-
ple, from 1 bird per pen for 9 pens per treatment, was 
solubilized in 10 mL extraction buffer (2 M urea, 50 mM 
ammonium bicarbonate). After homogenizing by vor-
texing and centrifugation (20 000 × g, 15 min, 4 °C), the 
supernatant was filtered through a 0.22 µm filter (Merck, 
Darmstadt, Germany) directly in a Vivaspin 20 with a 
5 kDa MWCO filter (Sartorius, Göttingen, Germany) and 
centrifuged for 1 h at 4000 × g. The filter was washed 3 
times with 1 mL extraction buffer followed by centrifuga-
tion (4000 × g, 10 min, 4 °C). The samples were washed 3 
times with 1 mL 500 mM triethylammonium bicarbonate 
buffer (TEABC, Sigma, Belgium) to remove the urea. 
Subsequently, the samples were concentrated to a volume 
of ± 500  µL. To determine the protein concentration, a 
Bradford assay was performed where OD was measured 
at 595 nm. Samples were diluted with TEABC buffer to 
obtain 50  µg of protein which was then reduced with 
dithiothreitol (DTT) from a 10 mM stock to a final con-
centration of 1  mM and incubated at 60  °C for 30  min, 
followed by alkylation for 10  min at room temperature 
with 200  mM methyl methanethiosulfonate (MMTS) to 
achieve a final concentration of 10 mM MMTS. Hereaf-
ter, 10 mM calcium chloride and 100% acetonitrile were 
added to a final concentration of 1 mM and 5% respec-
tively. Finally, trypsin of a 1 µg/µL stock was added in a 
1:20 (trypsin:protein) ratio for overnight digestion at 
37 °C. The samples were vacuum dried and analyzed with 
high performance liquid chromatography–mass spec-
trometry (HPLC–MS).
HPLC–MS
Peptides were dissolved in 0.1% formic acid in HPLC-
grade water (buffer A) to a final concentration of 1  µg/
µL. 100 fmol of mass prep digestion standard 2 (MPDS 
2) was spiked into each sample. Data Dependent Acqui-
sition MS analysis was performed on a TripleTOF 5600 
(Sciex, Darmstadt, Germany) fitted with a DuoSpray 
ion source in positive ion mode, coupled to an Eksigent 
NanoLC 400 HPLC system (Sciex). Peptides were sepa-
rated on a microLC YMC Triart C18 column (id 300 μm, 
length 15 cm, particle size 3 μm) at a flow rate of 5 μL/
min by means of trap-elute injection (YMC Triart C18 
guard column, id 500  μm, length 5  mm, particle size 
3 μm). Elution was performed using a gradient of 4–40% 
buffer B (0.1% formic acid, 5% DMSO in 80% ACN) over 
90 min. Ion source parameters were set to 5.5 kV for the 
ion spray voltage, 30  psi for the curtain gas, 13  psi for 
the nebulizer gas and 80 °C as temperature. For DDA, a 
2.25  s instrument cycle was repeated in high sensitivity 
mode throughout the whole gradient, consisting of a full 
scan MS spectrum (300–1250  m/z) with an accumula-
tion time of 0.2  s, followed by 20 MS/MS experiments 
(50–1800  m/z) with 0.2  s accumulation time each, on 
MS precursors with charge state 2 to 5+ exceeding a 500 
cps threshold. Rolling collision energy was used as sug-
gested by the manufacturer and former target ions were 
excluded for 10 s.
Database searching
The *.wiff files generated during LC–MS/MS analy-
sis were imported into the Progenesis QI for Prot-
eomics software (non-linear dynamics). The different 
samples were aligned based on retention time and m/z 
of reoccurring features to enable relative quantification. 
After subsequent peak picking, a merged *.mgf file was 
exported from the software and searched for identifica-
tions with MASCOT Daemon (Matrix Science, version 
2.5.1) against a chicken database (reviewed protein data-
base downloaded from Swissprot, January 2016) sup-
plemented with the cRAP database (laboratory proteins 
and dust/contact proteins) and the internal standard. 
Maximum peptide mass tolerance and fragment mass 
tolerance were set to 10  ppm and 0.1  Da respectively. 
Additionally, methylthio on cysteine was set as a fixed 
modification and deamidation of asparagine and/or glu-
tamine and oxidation of methionine were set as variable 
modifications. Enzyme specificity was set to trypsin with 
a maximum of one missed cleavage. The identifications 
were exported from MASCOT Daemon with a 1% false 
discovery rate (*.xml format) and imported into Progen-
esis QI for Proteomics.
Statistical analysis
Statistical analysis of performance parameters, macro-
scopic scoring, intestinal morphology and immunohis-
tochemistry was performed using Graphpad Prism (v.5, 
San Diego, USA). Statistical differences in macroscopic 
gut appearance and coccidiosis scores were determined 
using the Chi-square test. For the other parameters, pen 
(total of 3 birds per pen) was taken as experimental unit. 
To evaluate whether the data were normally distributed, 
a Kolmogorov–Smirnov test was performed. In case of 
a normal distribution, comparison between the control 
and challenge group was performed with an independent 
samples t-test. Otherwise, the non-parametric Mann–
Whitney test was performed. Progenesis (v4.1) was used 
Page 6 of 14De Meyer et al. Vet Res           (2019) 50:46 
for analysis of the proteomics data. Overall, a p-value of 
≤ 0.05 was considered statistically significant.
Results
Performance parameters
Body weight (BW), daily weight gain (DWG), daily feed 
intake (DFI) and feed conversion ratio (FCR) were meas-
ured at day 12 and 26. At day 26, challenged birds had a 
significant lower BW, DWG and DFI whereas FCR was 
increased (p < 0.05) (Table 3).
Macroscopic scoring
The scores for macroscopic gut wall appearance 
(3.11 ± 0.76 vs 0.92 ± 0.4) and coccidiosis (3.48 ± 1.14 vs 
0.82 ± 0.5) were higher in the challenge group compared 
to the control group respectively (p < 0.0001) (Figure 2).
Intestinal morphology and immunohistochemistry
Significantly shorter villi (1370 ± 158.7  µm vs 
2036 ± 134.6  µm), deeper crypts (365.7 ± 31.4  µm vs 
190.1 ± 15.4 µm), a lower villus-to-crypt ratio (3.85 ± 0.63 
vs 11.03 ± 1.03) and higher infiltration of  CD3+ cells 
(13.71 ± 2.22 area% vs 7.86 ± 0.77 area%) (p < 0.0001) 
were detected in the duodenal sections of animals from 
the challenge group as compared to the control group 
respectively (Figure 3).
Discovery proteomics
Using MASCOT Daemon (Matrix Science, version 
2.5.1) against a chicken database (reviewed protein data-
base downloaded from Swissprot, January 2016) sup-
plemented with the cRAP database (laboratory proteins 
and dust/contact proteins), 157 and 181 proteins were 
identified for colon and ileum respectively. In broil-
ers from the challenge group, the following proteins 
showed a significantly higher abundance compared to 
control animals in colonic content (p < 0.05): alpha-
actinin-4 (ACTN4), annexin A5 (ANXA5), apolipo-
protein A-1 (APOA1), fibronectin (FINC), hemoglobin 
subunit beta (HBB), myeloid protein 1 (MIM1), nucle-
ophosmin (NPM), ovoinhibitor (IOV7) and transthyretin 
(TTR). Both in colonic and ileal content, superoxide dis-
mutase [Cu–Zn] (SOD) showed a decreased abundance 
compared to control animals (p < 0.05). Angiotensin-
converting enzyme (ACE), mitochondrial aspartate ami-
notransferase (AATM), cathepsin D (CATD), Ig lambda 
chain C region (LAC), Ig lambda chain V-1 region (LV1), 
TTR and WD repeat-containing protein 1 (WDR1) 
showed a lower abundance in challenged birds (p < 0.05) 
in ileal samples. Following proteins were more abundant 
in challenged birds (p < 0.05): APOA1, histone H2A-IV 
(H2A4) and retinol-binding protein 4 (RET4) (Figure  4, 
Tables 4 and 5).  
Discussion
Intestinal inflammation models that do not induce clini-
cal signs, but affect zootechnical parameters by using 
triggers that are common under field conditions are the 
models of choice to identify biomarkers for intestinal 
health. Coccidiosis is the most common intestinal disease 
in broilers, and coccidiosis lesions caused by E. maxima 
and E. acervulina are frequently observed in broilers [26, 
27]. The diet shift, antibiotic treatment, and subsequent 
oral administration of a mix of bacterial opportunistic 
pathogens and commensals, was performed to mimic a 
decrease in bacterial diversity and to induce dysbiosis. 
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Figure 2 Macroscopic scoring parameters of intestine from broilers derived from the in vivo gut damage trial. Each dot represents 
the average score of 3 birds per pen with a total of 9 pens for control (white; n = 27) and challenged (black; n = 27) birds. A Macroscopic gut 
appearance score was determined by scoring of 10 parameters on assessment of absence (0) or presence (1) resulting in a total score between 0 
and 10. B Coccidiosis score was determined by the sum of the individual species scores, 0 if absent to 4 if severe, for lesions caused by Eimeria (E.) 
acervulina, E. maxima and E. tenella. Asterisk denotes statistical significance of p < 0.0001 between control and challenged animals.
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Feed changes to more non-starch polysaccharide (NSP) 
containing cereals (e.g. rye) have been shown to affect 
microbial composition and animal performance [10, 28]. 
E. coli and R. gnavus are enriched in human patients with 
inflammatory bowel disease (IBD) often characterized 
with increased disease activity [29]. Also excess accu-
mulation of lactic acid bacteria has been described to 
form part of a dysbiotic microbiota in humans, although 
these can also be beneficial, but this seems to be species 
and even strain dependent [30]. In addition, intestinal 
overgrowth of C. perfringens, even netB negative strains 
which are considered to be non-pathogenic for poultry, 
in combination with other predisposing factors such as 
Eimeria and indigestible NSPs are considered to induce 
small intestinal microbial perturbations [31]. The triggers 
used in the current model are thus biologically relevant, 
in contrast to chemical triggers of inflammation, such as 
dextran sulphate sodium (DSS), lipopolysaccharide (LPS) 
or feed restriction models that have been used in other 
studies in broilers [21, 32].
The model used in the current study led to shorter villi, 
deeper crypts and more infiltration of  CD3+ T-cells, in 
association with performance losses, but without clinical 
symptoms. These findings confirm that the in vivo model 
can be used to evaluate gut damage and to identify gut 
health biomarkers. Detection of protein biomarkers was 
performed in ileal and colonic content. The latter was 
chosen as a proxy for fecal material, to exclude issues 
that are related to protein breakdown in litter and lack 
of homogeneity of mixed fecal material, what are likely 
main problems in practical development of protein quan-
tification methods in the field.
In the current study, biomarker candidates were 
selected based on significant differences (p < 0.05) in pro-
tein abundance between control and challenged birds 
in ileal and/or colonic content. The normalized protein 
abundance mostly was higher in the ileal content com-
pared to the colonic content samples (Figure  4), which 
indicates that the used model induces proximal intestinal 
damage following release of host proteins in ileal content, 
and degradation of these proteins during passage further 
down the intestinal tract occurs.
The proteins that were identified as more abundant in 
challenged animals compared to control animals were 
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Figure 3 Histological parameters in duodenal sections from birds derived from the in vivo gut damage trial. 12 villi were randomly 
selected and measured per section and per animal using Leica DM LB2 microscope and a computer based image analysis program, LAS V4.1. Each 
dot represents the mean of 3 birds per pen with a total of 9 pens for control (white; n = 27) and challenged (black; n = 27) birds. A Villus length 
was measured from the crypt–villus junction to villus tip. B Crypt depth was measured from the junction to the base. C Villus-to-crypt ratio. D 
T-lymphocyte infiltration  (CD3 area%) was measured for a total area of 3.5 ± 0.5 mm2. Asterisk denotes statistical significance of p < 0.0001 between 
control and challenge group.
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Figure 4 Protein abundances in ileal and colonic content of birds from the in vivo gut damage trial. Proteomic analysis using high 
performance liquid chromatography–mass spectrometry (HPLC–MS) resulted in detection of proteins with a significant difference between groups 
in normalized abundance (p < 0.05) in ileal and/or colonic content. Each dot represents 1 bird per pen with a total of 9 pens for control (white; n = 9) 
and challenged (black; n = 9) animals.
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Figure 4 continued
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associated with inflammation, serum leakage and tissue 
destruction. A clear inflammation marker that was iden-
tified as more abundant in the colon of challenged ani-
mals was myeloid protein 1 (MIM1) and was the most 
discriminating protein detected between control and 
challenged birds (Table 4). Myeloid protein 1 is expressed 
in myeloid cells and is present in large amounts in secre-
tory granules of heterophilic granulocytes [33]. Amongst 
other leukocytes, activated heterophils can infiltrate the 
mucosa, transmigrate through the intestinal epithelium 
and degranulate in the intestinal lumen when an inflam-
matory trigger targets the epithelium [34, 35]. High fecal 
or intestinal content levels of MIM1 are thus specific for 
inflammatory intestinal disorders. In man, a neutrophil 
granule protein, calprotectin, is used in clinical practice 
to evaluate intestinal inflammation [36]. Fecal calprotec-
tin levels reflect disease activity in IBD [37]. The MIM1 
protein, and in extension all heterophil secretory granule 
proteins, may thus represent useful intestinal inflamma-
tion biomarkers.
Tissue damage markers are a second set of pro-
teins that are more abundant in the intestinal lumen 
of challenged compared to control animals. Damage 
of the intestinal epithelial barrier, invasion by micro-
organisms or entry of antigens in the mucosal tissue 
below the epithelial layer leads to mucosal inflamma-
tion and subsequent tissue damage [36]. Due to the 
tissue damage or destruction, tissue specific proteins 
can be released and end up in intestinal content. One 
of these proteins is fibronectin (FINC). Fibronectin is 
a high molecular weight glycoprotein that is found in 
the basement membrane and extracellular matrix in 
the intestinal wall (insoluble form) and in plasma (solu-
ble form) [38]. It has been shown that the expression 
of epithelial-derived fibronectin is highly upregulated 
in DSS-induced colitis models [39]. Fibronectin can 
potentiate cell attachment and wound healing through 
epithelial-matrix interactions and its expression is 
supposed to be vital for maintaining normal epithe-
lial integrity as well as regulating epithelial response 
to injury during colitis [39]. Intestinal damage in our 
current study could thus have resulted in an increased 
expression of epithelial or fibroblast-derived fibronec-
tin, release of matrix fibronectin or even leakage of 
plasma fibronectin, explaining the increased levels in 
the intestinal content of challenged animals.
Two nuclear proteins were identified as being more 
abundant in intestinal content of challenged animals, 
namely histone H2A-IV (H2A4) and nucleophosmin 
(NPM). H2A4 is a core component of nucleosomes that 
wraps and packages DNA into chromatin [40]. The high 
abundance in challenged animals may be explained by 
increased cell death. NPM is a phosphoprotein that ini-
tiates p53, a tumor suppressor gene which drives the 
cell to apoptosis [41]. Overexpression of NPM is associ-
ated with cell proliferation [42]. Parker et al. [43] states 
that cell proliferation within small intestinal crypts is 
the primary force that drives cell migration along the 
villus. Challenged broilers had longer crypts than the 
control animals which indicates more cell proliferation, 
likely in an attempt to repair lesions.
Epithelial damage has been shown to be associated 
with altered protein expression and distribution of 
intercellular connections, including tight junctions [44]. 
Alpha-actinin-4 (ACTN4), found to be more abundant 
in intestinal content in the challenge group as com-
pared to the control group, was shown to be localized 
in the apical part of chicken intestinal epithelial cells 
Table 4 Proteins of which the normalized abundance in colonic content was significantly different between control and 
challenged groups 
Proteomics using high performance liquid chromatography–mass spectrometry (HPLC–MS) was performed on colonic content of animals from the control (n = 9) 
and challenged (n = 9) group at day 26. This resulted in 9 proteins with a significantly higher normalize abundance (p < 0.05) and 1 protein with a significantly lower 
normalized abundance (p < 0.05) in challenged birds.
Accession number Protein name Abbreviation p-value Highest mean
Q90734 Alpha-actinin-4 ACTN4 0.0385 Challenge
P17153 Annexin A5 ANXA5 0.0266 Challenge
P08250 Apolipoprotein A-1 APOA1 0.0277 Challenge
P11722 Fibronectin FINC 0.0106 Challenge
P02112 Hemoglobin subunit beta HBB 0.0158 Challenge
P08940 Myeloid protein 1 MIM1 0.0008 Challenge
P16039 Nucleophosmin NPM 0.0071 Challenge
P10184 Ovoinhibitor IOV7 0.0254 Challenge
P80566 Superoxide dismutase [Cu–Zn] SOD 0.0287 Control
P27731 Transthyretin TTR 0.0317 Challenge
Page 11 of 14De Meyer et al. Vet Res           (2019) 50:46 
[45], more specifically as a component of the tight junc-
tion (zonula occludens) [46] and/or belt desmosomes 
(zonula adherens) [47]. Changes in gut permeability 
induced by enteric pathogens and/or parasites can also 
be the consequence of damage to these tight junctions 
[48]. Release of alpha-actinin-4 in the intestinal content 
of challenged animals might thus result from a higher 
expression and damaged tight junction and zonula 
adherens complexes.
Reduced tight junction integrity allows paracellular 
translocation of large molecules in both directions, thus 
loss of plasma proteins from the host into the intesti-
nal lumen and undesirable foreign substances from the 
lumen into the blood. Multiple proteins found to be 
higher abundant in the intestinal content of challenged 
animals are hypothesized to leak from the serum to the 
intestinal content because of mucosal damage. In our 
current model, the dysbiosis and the coccidial infection 
might have resulted in production of acute-phase pro-
teins (APPs) by the liver [49]. In mammalian species, 
APPs apolipoprotein A-1 (APOA1), transthyretin (TTR) 
and retinol-binding protein 4 (RET4) behave as negative 
APPs of which the concentration decreases in plasma 
during an acute phase response (APR). The exact behav-
ior of the expression in the liver of chickens is unknown 
[50]. Apolipoprotein A-1 (APOA1) is the major protein 
fraction of high-density lipoprotein (HDL) particles in 
plasma [51]. However, in avian species, APOA1 could 
also be expressed in numerous tissues other than the 
liver, such as absorptive intestinal epithelial cells, so our 
data could imply intestinal epithelial cell loss [52, 53]. 
Transthyretin (TTR) is a highly conserved protein in 
animal species that is involved in transport of thyroid 
hormones and retinol bound to retinol-binding protein 
4 (RET4) in the bloodstream [54]. Retinol (vitamin A) is 
known to be essential for differentiation and proliferation 
of epithelial cells [55]. Ovoinhibitor (IOV7) is a serine 
proteinase inhibitor that can reduce enzymatic diges-
tion by trypsin and chymotrypsin [56]. The detection 
of hemoglobin subunit beta (HBB) in intestinal content 
indicates that the administered challenges induced gut 
leakage and likely also endothelial damage allowing red 
blood cell leakage from the blood to the lumen.
A final protein that was found to be more abundant 
in colonic content of challenged animals is annexin A5 
(ANXA5). Both apoptotic and necrotic cells expose phos-
phatidylserine (PS), a major “eat-me” signal for phago-
cytes and for which ANXA5 binds with high affinity and 
specificity followed by initiation of an immune reac-
tion [57]. Van Genderen [58] suggests that the presence 
of extracellular ANXA5 is a consequence of release of 
cytosolic content from dead cells into the surrounding 
environment.
Proteins that were identified as less abundant in chal-
lenged animals compared to control animals were epi-
thelial cell activity markers and antibody components. 
A variety of peptidases, such as aminopeptidase Ey 
(AMPN) and angiotensin-converting enzyme (ACE), are 
localized in the intestinal brush border membrane and 
are involved as major functional enzymes in the final 
stage of protein digestion in the small intestine [59]. In 
case of bacterial infection, epithelial cells could be dam-
aged with loss of the functional brush border membrane. 
In rats, the distribution of ACE activity is highest in the 
proximal to middle region of the intestine, decreasing 
distally [59]. In our study, AMPN was annotated by more 
Table 5 Proteins of which the normalized abundance in ileal content was significantly different between control and 
challenged groups 
Proteomics using high performance liquid chromatography–mass spectrometry (HPLC–MS) was performed on ileal content of animals from the control (n = 9) and 
challenge (n = 9) group at day 26. This resulted in 3 proteins with a significantly higher normalized abundance (p < 0.05) and 9 proteins with a significantly lower 
normalized abundance (p < 0.05) in challenged birds.
Accession number Protein name Abbreviation p-value Highest mean
O57579 Aminopeptidase Ey AMPN 0.0012 Control
Q10751 Angiotensin-converting enzyme ACE 0.0006 Control
P08250 Apolipoprotein A-1 APOA1 0.0364 Challenge
P00508 Aspartate aminotransferase, mitochondrial AATM 0.0067 Control
Q05744 Cathepsin D CATD 0.0203 Control
P02263 Histone H2A-IV H2A4 0.0079 Challenge
P20763 Ig lambda chain C region LAC 0.0155 Control
P04210 Ig lambda chain V-1 region LV1 0.0370 Control
P41263 Retinol-binding protein 4 RET4 0.0399 Challenge
P80566 Superoxide dismutase [Cu–Zn] SOD 0.0004 Control
P27731 Transthyretin TTR 0.0091 Control
O93277 WD repeat-containing protein 1 WDR1 0.0027 Control
Page 12 of 14De Meyer et al. Vet Res           (2019) 50:46 
than 65 unique peptides, both in ileum and colon, while 
the average unique peptide level per protein was 6. This 
indicates a high chance of detectability and stability of 
AMPN in intestinal content. It seems plausible that lower 
concentrations of brush border enzymes are found when 
less epithelial cells are present, thus in the intestinal con-
tent of challenged animals.
It is probable that following proteins are linked to 
highly metabolically active cells which results in a 
reduced abundance in case of gut health problems. 
Superoxide dismutase [Cu–Zn] (SOD) catalyzes the dis-
mutation of superoxide radicals to hydrogen peroxide 
 (H2O2) and oxygen and contributes to enhanced small 
intestinal preservation in animals [60]. Superoxide dis-
mutases consist of three isoforms in mammals, namely 
the cytoplasmic, mitochondrial and extracellular Cu–Zn 
SOD [61]. Chicken SOD has 71.2%, 14.8% and 24.4% 
identity respectively with the human isoforms suggesting 
that in our study the cytoplasmic isoform of chicken SOD 
was identified. Mitochondrial aspartate aminotrans-
ferase (AATM), formerly known as glutamic-oxaloacetic 
transaminase, catalyzes the reaction of l-aspartate and 
2-oxoglutarate to oxaloacetate and glutamate [62]. WD 
(tryptophan-aspartate) repeat-containing protein 1 
(WDR1), also called actin-interacting protein 1 (AIP1), 
acts as a cofactor of ADF-cofilin and facilitates actin turn-
over by disassembly of actin filaments [63]. Lechuga [64] 
suggests that this protein is necessary for intestinal epi-
thelial morphogenesis due to its abundance at epithelial 
apical junctions which was substantiated with the obser-
vation that downregulation of AIP1 expression increased 
paracellular permeability and reduced junctional recruit-
ment of adherens and tight junction proteins. This is con-
sistent with our data, showing a reduced abundance in 
the ileum of challenged birds. Cathepsin D (CATD), an 
aspartic proteinase expressed in lysosomes, is the second 
most abundant protease after pepsin in the chicken gas-
trointestinal tract [65], thus suggesting that, in chicken, 
CATD may play additional roles, other than just being a 
“housekeeping enzyme” necessary for autophagy [66]. It 
could play a role as a digestive enzyme, as has been sug-
gested in fish [67].
Antibody light chain proteins were found less abun-
dant in the ileal content of challenged animals com-
pared to control animals. In birds, immunoglobulins 
IgA, IgM and IgY (also named chicken IgG) are anti-
bodies produced by B-cells as a response to presented 
antigens and consist of two heavy and light chains 
whereby birds only have one isotope of light chain, 
namely lambda (λ). The light chain is made up of a con-
stant, Ig lambda chain C region (LAC), and a variable 
region, Ig lambda chain V-1 region (LV1) [68]. IgAs are 
the most predominant class of antibodies in mucosal 
secretions with their primary function to maintain 
homeostasis at the mucosal surface and thus a steady-
state condition in the gut [69]. However, the reason for 
lower abundance in challenged birds is not clear.
In conclusion, using a broiler gut inflammation model, 
we have identified candidate intestinal biomarkers in 
ileal and/or colonic content of which concentrations 
differed significantly between control and challenged 
animals. Ideal potential biomarkers should be highly dis-
criminative between challenged and control groups, and 
have high but no overlapping numerical values between 
groups, to have a good chance of being applicable in the 
field. Since the model was developed using triggers that 
are common in field conditions, these potential biomark-
ers can serve as basis for validation in the field via devel-
opment of easy and rapid diagnostic tools as a method to 
detect and measure gut barrier failure in broilers.
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